
Accelerated Ventures invests £3.5m in Biosignatures
London-based Accelerated Ventures has invested £3.5m in Newcastle-headquartered biotechnology startup Biosignatures.
Latest News
Sponsor Capital acquires and merges Likeit, Nepton
Merged company will have combined revenues of around €8m in 2020, and employ over 50 staff.
Holland Capital invests in Cards PLM Solutions
Digitalisation and project life cycle management business intends to expand in DACH and Benelux
Sinergia Venture Fund holds €30m first close
Fund invests in pre-series-A and series-A rounds to support the growth of startups operating across a large variety of sectors
Octopus to launch £100m healthcare-focused fund
In conjunction with the announcement, the firm has hired an investment team from TenX Health
Back to Top